Your browser doesn't support javascript.
loading
How pharmacists would design and implement a community pharmacy-based colorectal cancer screening program.
Waters, Austin R; Meehan, Katherine; Atkins, Dana L; Ittes, Annika H; Ferrari, Renée M; Rohweder, Catherine L; Wangen, Mary; Ceballos, Rachel M; Issaka, Rachel B; Reuland, Daniel S; Wheeler, Stephanie B; Brenner, Alison T; Shah, Parth D.
Afiliação
  • Waters AR; Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27510, USA.
  • Meehan K; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27510, USA.
  • Atkins DL; Department of Pharmacy, University of Washington School of Pharmacy, Seattle, WA 98109, USA.
  • Ittes AH; Department of Medicine, University of Washington School of Medicine, Seattle, WA 98109, USA.
  • Ferrari RM; Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, WA 98109.
  • Rohweder CL; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27510, USA.
  • Wangen M; Center for Health Promotion and Disease Prevention, University of North Carolina, Chapel Hill, NC 27599, USA.
  • Ceballos RM; Center for Health Promotion and Disease Prevention, University of North Carolina, Chapel Hill, NC 27599, USA.
  • Issaka RB; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Reuland DS; Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, WA 98109.
  • Wheeler SB; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Brenner AT; Division of Gastroenterology, Department of Medicine, University of Washington School of Medicine. Seattle, WA, 98195, USA.
  • Shah PD; Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC 27510, USA.
Article em En | MEDLINE | ID: mdl-38881823
ABSTRACT

Background:

Distributing CRC screening through pharmacies, a highly accessible health service, may create opportunities for more equitable access to CRC screening. However, providing CRC screening in a new context introduces a substantial implementation challenge.

Methods:

We conducted 23 semi-structured interviews with community pharmacists practicing in Washington state and North Carolina about distributing fecal immunochemical tests (FIT) to patients in the pharmacy. The Consolidated Framework for Implementation Research (CFIR) was used to guide analysis.

Results:

Pharmacists believed that delivering FITs was highly compatible with their environment, workflow, and scope of practice. While knowledge about FIT eligibility criteria varied, pharmacists felt comfortable screening patients. They identified standardized eligibility criteria, patient-facing educational materials, and continuing education as essential design features. Pharmacists proposed adapting existing pharmacy electronic health record systems for patient reminders/prompts to facilitate FIT completion. While pharmacists felt confident that they could discuss test results with patients, they also expressed a need for stronger communication and care coordination with primary care providers.

Discussion:

When designing a pharmacy-based CRC screening program, pharmacists desired programmatic procedures to fit their current knowledge and context. Findings indicate that if proper attention is given to multi-level factors, FIT delivery can be extended to pharmacies.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article